<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Cambria;
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:Tahoma;
        panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
        {font-family:Georgia;
        panose-1:2 4 5 2 5 4 5 2 3 3;}
@font-face
        {font-family:Consolas;
        panose-1:2 11 6 9 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0cm;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";}
h1
        {mso-style-priority:9;
        mso-style-link:"Heading 1 Char";
        margin-top:24.0pt;
        margin-right:0cm;
        margin-bottom:0cm;
        margin-left:0cm;
        margin-bottom:.0001pt;
        page-break-after:avoid;
        font-size:14.0pt;
        font-family:"Cambria","serif";
        color:#365F91;
        font-weight:bold;}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:blue;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:purple;
        text-decoration:underline;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
        {mso-style-priority:99;
        mso-style-link:"Plain Text Char";
        margin:0cm;
        margin-bottom:.0001pt;
        font-size:10.5pt;
        font-family:Consolas;}
p
        {mso-style-priority:99;
        margin:0cm;
        margin-bottom:.0001pt;
        font-size:12.0pt;
        font-family:"Times New Roman","serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
        {mso-style-priority:99;
        mso-style-link:"Balloon Text Char";
        margin:0cm;
        margin-bottom:.0001pt;
        font-size:8.0pt;
        font-family:"Tahoma","sans-serif";}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
        {mso-style-priority:1;
        margin:0cm;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
        {mso-style-priority:34;
        margin-top:0cm;
        margin-right:0cm;
        margin-bottom:0cm;
        margin-left:36.0pt;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";}
span.Heading1Char
        {mso-style-name:"Heading 1 Char";
        mso-style-priority:9;
        mso-style-link:"Heading 1";
        font-family:"Cambria","serif";
        color:#365F91;
        font-weight:bold;}
span.PlainTextChar
        {mso-style-name:"Plain Text Char";
        mso-style-priority:99;
        mso-style-link:"Plain Text";
        font-family:Consolas;}
span.BalloonTextChar
        {mso-style-name:"Balloon Text Char";
        mso-style-priority:99;
        mso-style-link:"Balloon Text";
        font-family:"Tahoma","sans-serif";}
span.EmailStyle25
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:windowtext;}
span.EmailStyle26
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle27
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle28
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle29
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle30
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle31
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle32
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle33
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle34
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle35
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle36
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle37
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle38
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle39
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle40
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle41
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle42
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle43
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle44
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle45
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle46
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle47
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle48
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle49
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.apple-converted-space
        {mso-style-name:apple-converted-space;}
span.EmailStyle51
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle52
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle53
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle54
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle55
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle56
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle57
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle58
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle59
        {mso-style-type:personal-reply;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-size:10.0pt;}
@page WordSection1
        {size:612.0pt 792.0pt;
        margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
        {page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1027" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>See below for the monthly meeting announcement for PCCN Oakville/Mississauga.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Note worthy is the link to SABR at Sunnybrook where 5 doses of radiation is replacing the usual 39 doses.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Take care,<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>] <br><b>Sent:</b> July 12, 2018 12:18 AM<br><b>To:</b> PC Support Group<br><b>Subject:</b> PC Support Group Meeting Reminder<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="Picture_x0020_2" o:spid="_x0000_s1026" type="#_x0000_t75" alt="         OAKVILLE/MISSISSAUGA PROSTATE CANCER SUPPORT GROUP                                 (fellowship, emotional support, information and discussion) " style='position:absolute;margin-left:49.35pt;margin-top:2.05pt;width:540pt;height:46.15pt;z-index:251660288;visibility:visible;mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;mso-height-relative:margin'>
<v:imagedata src="cid:image001.wmz@01D419BE.8E7722C0" o:title="MISSISSAUGA PROSTATE CANCER SUPPORT GROUP                                 (fellowship, emotional support, information and discussion) " />
</v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:absolute;z-index:251660288;margin-left:66px;margin-top:3px;width:720px;height:62px'><img width=720 height=62 src="cid:image002.png@01D419BE.8E7722C0" alt="         OAKVILLE/MISSISSAUGA PROSTATE CANCER SUPPORT GROUP                                 (fellowship, emotional support, information and discussion) " v:shapes="Picture_x0020_2"></span><![endif]><b><span lang=EN-US style='font-size:12.0pt;font-family:"Georgia","serif";color:#1F497D'>                                                            </span></b><b><span lang=EN-US style='font-size:12.0pt;font-family:"Georgia","serif"'>     <span style='color:#1F497D'>     </span>   <span style='color:#1F497D'>                                                                                                                                      </span></span></b><b><span lang=EN-US><img width=161 height=99 id="Picture_x0020_5" src="cid:image005.jpg@01CF0BC1.574D6F80" alt="cid:image001.jpg@01CDF27E.DB1D8B40"></span></b><b><span lang=EN-US style='font-size:12.0pt;font-family:"Georgia","serif";color:#1F497D'>                                       </span></b><b><span lang=EN-US style='font-size:12.0pt;font-family:"Georgia","serif"'>  </span></b><b><span lang=EN-US style='color:#1F497D'>                                    </span></b><b><span lang=EN-US style='font-size:12.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p></o:p></span></b></p><p class=MsoNormal><b><i><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p> </o:p></span></i></b></p><p class=MsoNormal><b><span lang=EN-US style='font-size:14.0pt;font-family:"Georgia","serif";color:#1F497D'>Hi everyone. Here is your reminder that our next meeting is on <o:p></o:p></span></b></p><p class=MsoNormal><b><span lang=EN-US style='font-size:14.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p> </o:p></span></b></p><p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-US style='font-size:14.0pt;font-family:"Georgia","serif";color:#1F497D'>WEDNESDAY JULY 18th</span></b><b><span lang=EN-US style='font-size:14.0pt;font-family:"Georgia","serif";color:red'> </span></b><b><span lang=EN-US style='font-size:14.0pt;font-family:"Georgia","serif"'>- 7:00 PM  at the WELLSPRING CENTRE,</span></b><span lang=EN-US style='font-size:14.0pt;font-family:"Georgia","serif"'> </span><b><span lang=EN-US style='font-size:14.0pt;font-family:"Cambria","serif"'>2545</span></b><b><span lang=EN-US style='font-size:14.0pt;font-family:"Georgia","serif"'> SIXTH LINE in OAKVILLE<o:p></o:p></span></b></p><p class=MsoNormal><span lang=EN-US style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Georgia","serif"'><o:p> </o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;background:white'><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'>I don’t have to tell you that <b>incontinence</b> is a common side effect of treatment for prostate cancer, especially after prostatectomy surgery.<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;background:white'><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'>For those who suffer from incontinence, there is a series of steps that can be taken to minimize the effects. The first is to do pelvic floor strengthening – Kegel exercises. Trouble is, it seems that most of us don’t know how to do these properly.<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;background:white'><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'>Come to our <b>July 18</b> meeting and meet the physiotherapists from </span><span lang=EN-US><a href="https://www.blueberrytherapy.ca/physiotherapy" target="_blank"><b><span style='font-size:13.0pt;font-family:"Georgia","serif";color:windowtext'>Blueberry Therapy</span></b></a></span><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'> who will show us how to do Kegels properly and will discuss the other exercises and procedures they have to help restore pelvic floor strength.<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;background:white'><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'>So no matter whether you are about to have treatment, have recently finished treatment or are just putting it down to the effects of aging, there will be advice and answers for you at this meeting.<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;background:white'><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'>I look forward to seeing everyone there.<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;background:white'><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'><o:p> </o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;background:white'><b><u><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'>Interesting Information I have seen this Month<o:p></o:p></span></u></b></p><p class=MsoNormal style='margin-bottom:7.5pt;background:white'><b><u><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'><o:p><span style='text-decoration:none'> </span></o:p></span></u></b></p><p class=MsoNormal style='margin-bottom:7.5pt;background:white'><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'>More on SABR at Sunnybrook – 5 radiation treatments instead of 39 </span><span lang=EN-US><a href="https://sunnybrook.ca/media/item.asp?c=1&i=1742&page=33939"><span style='font-size:13.0pt;font-family:"Georgia","serif"'>https://sunnybrook.ca/media/item.asp?c=1&i=1742&page=33939</span></a></span><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'><o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;background:white'><b><u><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'><o:p><span style='text-decoration:none'> </span></o:p></span></u></b></p><p class=MsoNormal style='margin-bottom:7.5pt;background:white'><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'>Another study showing the merits of MRI over a standard biopsy to detect clinically-significant prostate cancer<br></span><span lang=EN-US><a href="https://www.urotoday.com/conference-highlights/eau-2018/eau-2018-prostate-cancer/102886-eau-2018-game-changer-prostate-evaluation-for-clinically-important-disease-sampling-using-image-guidance-or-not-the-precision-study.html"><span style='font-size:13.0pt;font-family:"Georgia","serif"'>https://www.urotoday.com/conference-highlights/eau-2018/eau-2018-prostate-cancer/102886-eau-2018-game-changer-prostate-evaluation-for-clinically-important-disease-sampling-using-image-guidance-or-not-the-precision-study.html</span></a></span><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'><o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;background:white'><i><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'>“</span></i><i><span lang=EN-US style='font-family:"Arial","sans-serif";color:#333333;background:white'>In summary, this important trial demonstrated that in men with a clinical suspicion of PC, risk assessment with mpMRI before biopsy, and MRI-targeted biopsy in the presence of a suspicious lesion, was superior to the diagnostic pathway of standard TRUS–guided biopsy.”<o:p></o:p></span></i></p><p class=MsoNormal style='margin-bottom:7.5pt;background:white'><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'><br>PSMA (prostate specific membrane antigen) is another abbreviation we are going to have to learn. The key point here seems to be that PSMA-PET scans can find where the disease is hiding when PSA starts to go back up after primary treatment. A radiotracer such as gallium 68 binds to the PSMA and can be detected by a PET scan. That way, specific radiation treatment to the correct area can be initiated earlier.<br><br></span><i><span lang=EN-US style='font-size:10.0pt;font-family:"Arial","sans-serif";color:black;background:white'>“ </span></i><i><span lang=EN-US style='font-family:"Arial","sans-serif";color:black;background:white'>In patients with primary prostate cancer of intermediate-risk to high-risk, PSMA-based imaging has been reported to improve detection of metastatic disease compared with CT or mpMRI, rendering additional cross-sectional imaging or bone scintigraphy unnecessary. Furthermore, in patients with biochemically recurrent prostate cancer, use of (68)Ga-PSMA-PET imaging has been shown to increase detection of metastatic sites, even at low serum PSA values, compared with conventional imaging or PET examination with different tracers.”</span></i><i><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif"'><o:p></o:p></span></i></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><b><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>Walter<o:p></o:p></span></b></p><p class=MsoNormal><b><u><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p><span style='text-decoration:none'> </span></o:p></span></u></b></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p> </o:p></span></p></div></body></html>